abstract |
In some aspects, the invention relates to engineered endothelial cells, e.g., E4ORF1+ ETV2+ engineered endothelial cells. In other aspects, the invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, e.g., in co-culture applications. |